GLOFITAMAB-GXBM for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 55 adverse event reports in the FDA FAERS database where GLOFITAMAB-GXBM was used for Product used for unknown indication.
Most Reported Side Effects for GLOFITAMAB-GXBM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 107 | 21.5% | 16 | 41 |
| Disease progression | 68 | 13.7% | 40 | 13 |
| Off label use | 68 | 13.7% | 9 | 17 |
| Death | 67 | 13.5% | 67 | 6 |
| Pyrexia | 45 | 9.0% | 12 | 8 |
| No adverse event | 28 | 5.6% | 0 | 0 |
| Immune effector cell-associated neurotoxicity syndrome | 25 | 5.0% | 13 | 18 |
| Infection | 20 | 4.0% | 11 | 13 |
| Pneumonia | 14 | 2.8% | 9 | 3 |
| Condition aggravated | 12 | 2.4% | 11 | 0 |
| Covid-19 | 10 | 2.0% | 4 | 3 |
| Drug ineffective | 10 | 2.0% | 4 | 2 |
| Sepsis | 10 | 2.0% | 5 | 5 |
| Diffuse large b-cell lymphoma recurrent | 9 | 1.8% | 0 | 1 |
| Dyspnoea | 9 | 1.8% | 2 | 5 |
Other Indications for GLOFITAMAB-GXBM
Diffuse large b-cell lymphoma (313)
Diffuse large b-cell lymphoma refractory (38)
B-cell lymphoma (20)
Mantle cell lymphoma (18)
Diffuse large b-cell lymphoma recurrent (10)
Follicular lymphoma (7)
Burkitt's lymphoma (6)
Lymphoma (6)
Lymphoma transformation (5)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)